Remdesivir initially showed a trend in reducing the time to clinical improvement [11] .
← all excerpts
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
1
—
—
Remdesivir initially showed a trend in reducing the time to clinical improvement [11] .